L 52/30
EN
Official Journal of the European Union
20.2.2023
(ii) the donor animals were kept, during the 60 days prior to the date of collection of the semen, oocytes or embryos, in an artificial insemination centre or other appropriate establishment where, within a radius of at least 20 km, no outbreak of LSD has been confirmed during the three months prior to the date of collection of the semen, oocytes or embryos; (iii) the donor animals were clinically checked 28 days prior to the date of collection, as well as throughout the entire collection period, and did not show any clinical symptoms of LSD; (b) any destination located in another vaccination zone I or II of another Member State, provided that, in addition to the conditions laid down in point (a), all of the following conditions are fulfilled: (i) the donor animals were subjected, with negative results, to a polymerase chain reaction (PCR) test to detect LSD conducted on blood samples collected at the commencement of collection of the semen and at least every 14 days thereafter during the semen collection period or on the day of collection for embryos and oocytes; (ii) the semen was subjected, with negative results, to a PCR test to detect LSD; (c) any destination located in the same or another Member State or, in case of a vaccination zone I, to a third country provided that, in addition to the conditions laid down in point (a), the donor animals comply with any other appropriate animal health guarantees, based on a positive outcome of a risk assessment of the impact of such dispatch and of the measures against the spread of LSD, required by the competent authority of the Member State of the establishment of origin and approved by the competent authorities of the Member States of the places of passage and of destination, prior to the dispatch of such semen, oocytes or embryos.
3.4.2.
Movements of consignments of semen, oocytes and embryos of bovine animals, may be authorised from approved germinal product establishments or other establishments located in a vaccination zone II to any destination located in another vaccination zone II of the same Member State. 3.5.
Movements of consignments of unprocessed animal by-products from bovine animals from vaccination zones I: Movements of consignments of unprocessed animal by-products from bovine animals may be authorised from establishments located in a vaccination zone I to: (a) any destination located in the same Member State or to any destination located in vaccination zones I or II of another Member State; (b) in the case of consignments of hides and skins, any destination located in any area of the same or another Member State or third country provided that one of the following conditions is fulfilled: (i) the treated hides and skins have been subjected to one of the treatments referred to in point 28(b) to (e) of Annex I to Commission Regulation (EU) No 142/2011 (1); or (ii) the treated hides and skin have been subjected to one of the treatments set out in Section XIV, Chapter I, point (4)(b)(ii), of Annex III to Regulation (EC) No 853/2004 of the European Parliament and of the Council (2), and have undergone all precautions to avoid recontamination with pathogenic agents after treatment.
(1) Commission Regulation (EU) No 142/2011 of 25 February 2011 implementing Regulation (EC) No 1069/2009 of the European Parliament and of the Council laying down health rules as regards animal by-products and derived products not intended for human consumption and implementing Council Directive 97/78/EC as regards certain samples and items exempt from veterinary checks at the border under that Directive (OJ L 54, 26.2.2011, p. 1).
(2) Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific hygiene rules for food of animal origin (OJ L 139, 30.4.2004, p. 55).